Certified Advisory Corp Eli Lilly & CO Transaction History

Certified Advisory Corp

$882 Million
Q3 2024

A detailed history of Certified Advisory Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Certified Advisory Corp holds 4,095 shares of LLY stock, worth $3.06 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares

4,095

Previous 4,064 0.76%

Holding current value

$3.06 Million

Previous $3.68 Million 1.41%

% of portfolio

0.41%

Previous 0.47%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$772.14 - $960.02 $23,936 - $29,760	31 Added 0.76%	4,095 $3.63 Million
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $102,931 - $129,083	142 Added 3.62%	4,064 $3.68 Million
Q1 2024 May 10, 2024	SELL	$592.2 - $792.28 $4,737 - $6,338	-8 Reduced 0.2%	3,922 $3.05 Million
Q4 2023 Feb 09, 2024	SELL	$525.19 - $619.13 $17.5 Million - $20.6 Million	-33,264 Reduced 89.43%	3,930 $2.29 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $14.5 Million - $20 Million	33,435 Added 889.47%	37,194 $20 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $16,484 - $22,042	-47 Reduced 1.23%	3,759 $1.76 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $85,423 - $100,325	275 Added 7.79%	3,806 $1.31 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $20,900 - $24,353	-65 Reduced 1.81%	3,531 $1.29 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $10,376 - $11,825	35 Added 0.98%	3,596 $1.16 Million
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $234 - $291	1 Added 0.03%	3,561 $1.02 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $39,348 - $48,832	-175 Reduced 4.69%	3,560 $983,000
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $5,761 - $7,090	-26 Reduced 0.69%	3,735 $863,000
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $625,786 - $809,449	3,466 Added 1174.92%	3,761 $863,000
Q1 2021 May 10, 2021	BUY	$164.32 - $212.72 $11,338 - $14,677	69 Added 30.53%	295 $55,000
Q2 2020 Jul 27, 2020	BUY	$136.42 - $164.18 $136 - $164	1 Added 0.44%	226 $37,000
Q4 2019 Jan 29, 2020	BUY	$106.92 - $132.43 $106 - $132	1 Added 0.45%	225 $30,000
Q3 2019 Nov 12, 2019	BUY	$106.79 - $116.16 $4,378 - $4,762	41 Added 22.4%	224 $25,000
Q2 2019 Aug 07, 2019	BUY	$110.79 - $129.32 $110 - $129	1 Added 0.55%	183 $20,000
Q1 2019 May 07, 2019	SELL	$111.31 - $131.02 $1,335 - $1,572	-12 Reduced 6.19%	182 $24,000
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $257 - $321	3 Added 1.57%	194 $20,000
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $75 - $86	1 Added 0.53%	191 $16,000
Q1 2018 Apr 30, 2018	BUY	$74.21 - $87.6 $5,639 - $6,657	76 Added 66.67%	190 $13,000
Q4 2017 Feb 22, 2018	BUY	$81.94 - $87.89 $9,341 - $10,019	114	114 $8,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Certified Advisory Corp, based on Form 13F filings with the SEC.

News

Stay updated on Certified Advisory Corp with notifications on news.

Account

Certified Advisory Corp Eli Lilly & CO Transaction History